ConductScience.org, home

Paper8429263

Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.

Dejager S and 2 others. J Lipid Res, 1993. Cited by 203 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. Papers, record 8429263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8429263

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.
PubMed
Journal
J Lipid Res
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
203
iCite
Relative citation ratio, by iCite
6.62
iCite
Revised in PubMed
2021-02-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dejager SS
2Bruckert EE
3Chapman MJM J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lipoproteins, LDLMajor topic
Adult
Centrifugation, Density Gradient
Chemical Phenomena
Chemistry, Physical
Humans
Hyperlipidemia, Familial Combined
Lipid Peroxides
Lipoprotein(a)
Male
Middle Aged
Oxidation-Reduction
Particle Size
Vitamin E

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01384058Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 DiabetesBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.

PMIDTitleJournalYearIn PapersSource
42189392Desialylated vs. Oxidized LDL: Sialidase Inhibitors as Promising Antiatherosclerotic Agents.Curr Atheroscler Rep2026https://conductscience.org/library/papers/42189392PubMed
41210345LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review.Front Cardiovasc Med2025https://conductscience.org/library/papers/41210345PubMed
40583516The Link between Lipids and Inflammation: Focus on Targeting Sialidase Activity as a Novel Strategy for Anti-Atherosclerotic Therapy.Curr Med Chem2025https://conductscience.org/library/papers/40583516PubMed
38750162Effects of phytosterol supplementation on lipoprotein subfractions and LDL particle quality.Sci Rep2024https://conductscience.org/library/papers/38750162PubMed
38494931We Must Abandon the Myth: Oxidized Low-density Lipoprotein is not a Lipoprotein that Plays a Key Role in Atherogenesis.Curr Med Chem2025https://conductscience.org/library/papers/38494931PubMed
37812346Should We "RESPECT EPA" More Now? EPA and DHA for Cardiovascular Risk Reduction.Curr Cardiol Rep2023https://conductscience.org/library/papers/37812346PubMed
34362390The effects of fat consumption on low-density lipoprotein particle size in healthy individuals: a narrative review.Lipids Health Dis2021https://conductscience.org/library/papers/34362390PubMed
32245386Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study.Cardiovasc Diabetol2020https://conductscience.org/library/papers/32245386PubMed
30283212High Hydrostatic Pressure Induces a Lipid Phase Transition and Molecular Rearrangements in Low-Density Lipoprotein Nanoparticles.Part Part Syst Charact2018https://conductscience.org/library/papers/30283212PubMed
28797250Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.Lipids Health Dis2017https://conductscience.org/library/papers/28797250PubMed
28382948High hydrostatic pressure specifically affects molecular dynamics and shape of low-density lipoprotein particles.Sci Rep2017https://conductscience.org/library/papers/28382948PubMed
25849089Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.PLoS One2015https://conductscience.org/library/papers/25849089PubMed
24683220Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study.Curr Ther Res Clin Exp2009https://conductscience.org/library/papers/24683220PubMed
24558110Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.Arterioscler Thromb Vasc Biol2014https://conductscience.org/library/papers/24558110PubMed
24264394An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes.Diabetes2013https://conductscience.org/library/papers/24264394PubMed
20574778Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk.Lipids2010https://conductscience.org/library/papers/20574778PubMed
20421882Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.Nat Rev Endocrinol2010https://conductscience.org/library/papers/20421882PubMed
18797861Molecular structure of low density lipoprotein: current status and future challenges.Eur Biophys J2009https://conductscience.org/library/papers/18797861PubMed
17045077Alterations in lipoprotein defense against oxidative stress in metabolic syndrome.Curr Atheroscler Rep2006https://conductscience.org/library/papers/17045077PubMed
16943850
Dietary polyunsaturated fat intake is associated with low-density lipoprotein size, but not with susceptibility to oxidation in subjects with impaired glucose metabolism and type II diabetes: the Hoorn study.
Eur J Clin Nutr2007https://conductscience.org/library/papers/16943850PubMed

See all 31 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APOB338PubTator's text mininghttps://conductscience.org/library/genes/338

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8429263

GET https://conductscience.org/api/papers/v1/8429263/cited_by?page=2